Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas-Reference-Cited by-同舟云学术

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

Published:2017-09-30 Issue:49 Volume:8 Page:86769-86783
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Carew Jennifer S.¹,Espitia Claudia M.²,Zhao Weiguo²,Mita Monica M.³,Mita Alain C.³,Nawrocki Steffan T.¹

Affiliation:

1. University of Arizona Cancer Center and Department of Medicine, Division of Translational and Regenerative Medicine, University of Arizona, Tucson, AZ, USA

2. Division of Hematology/Oncology, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

3. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-09

2. The COMPASS complex maintains the metastatic capacity imparted by a subpopulation of cells in UPS;iScience;2024-07

3. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

4. Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation;Investigative Opthalmology & Visual Science;2024-01-08

5. A promising future in cancer immunotherapy: Oncolytic viruses;European Journal of Pharmacology;2023-12